ATRI Atrion Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: ATRI

Price (delayed)

$298.295

Market cap

$524.95M

P/E Ratio

24.69

Dividend/share

$8.65

EPS

$12.08

Enterprise value

$528.79M

Atrion Corporation is a leading supplier of medical devices and components to niche markets in the health care and medical industry. Atrion's proprietary products, ranging from cardiovascular and ophthalmology products ...

Highlights
The stock's P/E is 33% below its 5-year quarterly average of 36.8 and 28% below its last 4 quarters average of 34.2
Atrion's quick ratio has plunged by 53% YoY but it has increased by 2.8% from the previous quarter
ATRI's net income is down by 39% year-on-year and by 22% since the previous quarter
The EPS has decreased by 38% YoY and by 21% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.atrioncorp.com
Peers: COO STAA TFX VUZI

Key stats

What are the main financial stats of ATRI
Market
Shares outstanding
1.76M
Market cap
$524.95M
Enterprise value
$528.79M
Valuations
Price to earnings (P/E)
24.69
Price to book (P/B)
2.19
Price to sales (P/S)
3.11
EV/EBIT
22.01
EV/EBITDA
13.7
EV/Sales
3.14
Earnings
Revenue
$168.6M
EBIT
$24.02M
EBITDA
$38.59M
Free cash flow
-$19.18M
Per share
EPS
$12.08
Free cash flow per share
-$10.9
Book value per share
$136.49
Revenue per share
$95.79
TBVPS
$144.31
Balance sheet
Total assets
$264.81M
Total liabilities
$24.63M
Debt
$4.5M
Equity
$240.18M
Working capital
$100.48M
Liquidity
Debt to equity
0.02
Current ratio
7.58
Quick ratio
1.82
Net debt/EBITDA
0.1
Margins
EBITDA margin
22.9%
Gross margin
38.1%
Net margin
12.6%
Operating margin
14.7%
Efficiency
Return on assets
8.1%
Return on equity
8.9%
Return on invested capital
10.2%
Return on capital employed
9.6%
Return on sales
14.2%
Dividend
Dividend yield
2.9%
DPS
$8.65
Payout ratio
71.6%

ATRI stock price

How has the Atrion stock price performed over time
Intraday
0.54%
1 week
0.97%
1 month
-13.08%
1 year
-48.52%
YTD
-46.68%
QTD
-27.8%

Financial performance

How have Atrion's revenue and profit performed over time
Revenue
$168.6M
Gross profit
$64.25M
Operating income
$24.72M
Net income
$21.31M
Gross margin
38.1%
Net margin
12.6%
ATRI's net income is down by 39% year-on-year and by 22% since the previous quarter
Atrion's operating income has decreased by 36% YoY and by 18% from the previous quarter
Atrion's net margin has decreased by 34% YoY and by 21% QoQ
The operating margin has contracted by 31% YoY and by 17% from the previous quarter

Growth

What is Atrion's growth rate over time

Valuation

What is Atrion stock price valuation
ATRI P/E details
P/E
24.69
P/B
2.19
P/S
3.11
EV/EBIT
22.01
EV/EBITDA
13.7
EV/Sales
3.14
The EPS has decreased by 38% YoY and by 21% from the previous quarter
The stock's P/E is 33% below its 5-year quarterly average of 36.8 and 28% below its last 4 quarters average of 34.2
The stock's price to book (P/B) is 57% less than its 5-year quarterly average of 5.1 and 46% less than its last 4 quarters average of 4.0
The company's equity fell by 2.5% YoY
ATRI's P/S is 59% below its 5-year quarterly average of 7.6 and 44% below its last 4 quarters average of 5.5
ATRI's revenue is down by 7% year-on-year

Efficiency

How efficient is Atrion business performance
The ROIC has contracted by 45% YoY and by 24% from the previous quarter
ATRI's return on assets is down by 37% year-on-year and by 21% since the previous quarter
ATRI's return on equity is down by 37% year-on-year and by 21% since the previous quarter
The ROS has decreased by 37% YoY and by 22% from the previous quarter

Dividends

What is ATRI's dividend history
Dividend details
DPS
$8.65
Dividend yield
2.9%
Payout ratio
71.6%
Recent dividends

Financial health

How did Atrion financials performed over time
Atrion's quick ratio has plunged by 53% YoY but it has increased by 2.8% from the previous quarter
ATRI's current ratio is up by 7% since the previous quarter and by 2.2% year-on-year
Atrion's debt is 98% lower than its equity
Atrion's debt has increased by 17% QoQ
The company's equity fell by 2.5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.